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Abstract
Melioidosis is a disease in tropical and subtropical regions of the world that is caused by Burkholderia pseudomallei. In
endemic regions the disease occurs primarily in humans and goats. In the present study, we used the goat as a model to
dissect the polar lipids of B. pseudomallei to identify lipid molecules that could be used for adjuvants/vaccines or as
diagnostic tools. We showed that the lipidome of B. pseudomallei and its fractions contain several polar lipids with the
capacity to elicit different immune responses in goats, namely rhamnolipids and ornithine lipids which induced IFN-c,
whereas phospholipids and an undefined polar lipid induced strong IL-10 secretion in CD4+ T cells. Autologous T cells co-
cultured with caprine dendritic cells (cDCs) and polar lipids of B. pseudomallei proliferated and up-regulated the expression
of CD25 (IL-2 receptor) molecules. Furthermore, we demonstrated that polar lipids were able to up-regulate CD1w2 antigen
expression in cDCs derived from peripheral blood monocytes. Interestingly, the same polar lipids had only little effect on the
expression of MHC class II DR antigens in the same caprine dendritic cells. Finally, antibody blocking of the CD1w2
molecules on cDCs resulted in decreased expression for IFN-c by CD4+ T cells. Altogether, these results showed that polar
lipids of B. pseudomallei are recognized by the caprine immune system and that their recognition is primarily mediated by
the CD1 antigen cluster.
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Introduction
Interest in the pathogenesis of infection with Burkholderia
pseudomallei, the causative agent of melioidosis, and the related
pathogen B. mallei which causes glanders disease, has substantially
increased following their classification in the United States as
category B priority and more recently Tier 1 pathogens with
biothreat potential. While melioidosis has traditionally been
recognized as an endemic disease in Southeast Asia and Northern
Australia, it is now increasingly diagnosed in other tropical and
subtropical regions of the world, including South and Central
America, Africa and and the Indian subcontinent [1,2,3,4]. These
findings are consistent with the notion that melioidosis is greatly
under- or misdiagnosed and probably endemic throughout most of
the subtropical and tropical regions of the world. Melioidosis is
refractory to antibiotic therapy and requires aggressive and
lengthy acute and eradication phase treatments [5]. In addition,
recurrent infections with the same or different strains of B.
pseudomallei are common after antibiotic treatment [6]. Further-
more, at present there are no licensed vaccines to prevent this
infection. It is believed that lack of appropriate tools for diagnosis
and lack of adequate treatment for chronic and/or recurrent
melioidosis are responsible for the current epidemiological
scenario of melioidosis. Thus, new strategies for diagnostics,
therapeutics, and vaccines are needed.
Development of prophylactics for melioidosis requires definition
of correlates of immune protection against B. pseudomallei infection.
In the early stages of infection, NK and T cells are important but
not essential [7,8,9,10,11,12]. On the other hand IFN-c, IL-12,
and IL-18 cytokine expression are required, and it appears that
multiple cell types release these cytokines early post-infection
[8,13,14]. However, during the late stages of infection, antigen-
specific T cells, mainly CD4+ T cells producing IFN-c are essential
for protection [8,14,15]. Some of these IFN-c+CD4+ T cells have
demonstrated the capacity to respond to specific B. pseudomallei
proteins in mice and in humans [8,9,16,17,18,19]. It has been
suggested that the main function of IFN-c is activation of
macrophages, however the exact mechanism(s) involved in the
production of IFN-c during the infection or why there is
incomplete protection against this pathogen are still unknown.
In addition, it is unknown, which mechanisms counteract the
protective antimicrobial effect generated by this cytokine. Finally,
there is still a lack of knowledge on the potential role of
immunosuppressive cytokine(s) and regulatory cells generated
during B. pseudomallei infection, and these gaps have not been
addressed in recent research efforts.
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Bacterial cell envelopes are known to contain a wide array of
lipids and the majority of them – phospholipids – are integral
components of the cytosolic membrane. The amount and the
variety of lipids are different and specific for each bacterial genus
and/or species. While it is well known for mycobacteria,
corynebacteria, and Nocardia spp. that their cell envelopes contain
up to 40% of lipids, other bacteria like Francisella spp. or
Mycoplasma spp. contain only low amounts and few distinct lipids.
For a long time it was assumed that B. pseudomallei does not contain
large amounts of lipids and that most of them are phospholipids
and rhamnolipids, which were mostly viewed as exopolysacchar-
ides but not lipids. However, recent studies revealed that the cell
envelope of B. pseudomallei does not contain a wide array of lipids
and carbohydrates. Several of these molecules are noted for
immunological activities. Phung et al. (1995) identified a highly
polar glycolipid, later identified as rhamnolipid that could be used
as a diagnostic tool using sera from humans with melioidosis [20].
Four surface polysaccharides are proposed for B. pseudomallei
according to genomic analyses and two of them were character-
ized in more detail: capsular polysaccharide (or type I O-PS) and
type II O-PS [21,22,23]. The type II O-antigenic polysaccharide
moiety of B. pseudomallei lipopolysaccharide is required for serum
resistance and virulence [21,22].
Bacterial lipids can be divided into non-polar lipids, phospho-
lipids, and polar lipids. While knowledge about the function of
non-polar lipids is limited, more is known about phospholipids
because they are membrane constituents. Polar lipids on the other
hand are increasingly being recognized as playing roles in host-
pathogen interaction and as stimulators of humoral and cellular
immune responses. In other bacterial infections, it has been
described that lipids are presented by dendritic cells bearing the
CD1 molecule and are recognized as specific antigens by CD1-
restricted T cells [24,25]. We hypothesized that characterization of
the contingent of lipids of B. pseudomallei and their abundance
would contribute to the understanding of the pathogenic
mechanisms of this bacterium and the host’s response to infection.
Thus, in this study we demonstrated that polar lipids of B.
pseudomallei presented by caprine DCs can elicit immune T cell
responses and that CD1w2 (CD1b antigens in humans) antigens
participate in this process.
Materials and Methods
Chemical Reagents
All chemical reagents were of the highest grade available and
obtained from Sigma-Aldrich, LLC (St. Louis, MO) unless
otherwise specified.
Lipid isolation and antigen preparation
B. pseudomallei strain K96243 [26] was grown for 16 h in
Middlebrook 7H9 medium supplemented with glucose at a final
concentration of 0.2%. The wet cell pellet was treated with
chloroform/methanol (1:1) at a ratio of 10:1 (vol/vol) for seven
days at 4uC. This unusual extraction time was necessary to ensure
that the bacteria were dead and the mixture could be transferred
out of the BSL-3 laboratory. After centrifugation the supernatant
was used for the first extraction containing all cell envelope lipids
(termed F1) and the remaining cell debris pellet was dried under
nitrogen. A second extraction was performed on dried residue cell
debris with chloroform/methanol (2:1) and the supernatant from
this extraction was used for the second extraction, which contained
only polar lipids (termed F2). Each one of the extractions was
purified by Folch-washing with 6 ml chloroform/methanol (2:1)
and 1 ml of water. The organic phase was transferred to a new
pre-weight tube and dried down under a constant stream of
nitrogen. The extracted and purified lipids were suspended in
chloroform/methanol (2:1) to a concentration of 10 mg/ml. Lipids
were analyzed and separated by two dimensional thin layer
chromatography (2D-TLC) in five different solvent systems on
aluminum-backed silica 60 F254 gel plates (EMD Chemicals,
Gibbstown, NJ) (Table 1). Lipids were visualized by spraying with
10% CuSO4 in 8% H3PO4 followed by heating or by exposure to
UV light. Lipids were further analyzed by differential spraying of
the plates to detect carbohydrates (a-naphthol solution), primary,
secondary, and tertiary amino groups (using ninhydrin spray
solution), and negatively charged groups (primarily phosphates)
(using Dittmer-Lester spray solution).
Material from the second extraction contained only polar lipids
and was further fractionated on a silica 60 gel column with
increasing concentrations of methanol in chloroform: 67% for
fraction V (termed F4), 75% for fraction VI (termed F5), 80% for
fraction VII (termed F6), and 90% for fraction VIII (termed F7).
Lipid fractions were purified by Folch wash, which also removes
endotoxin. For the preparation of each tested lipid fraction
endotoxin-free water and solutions were used. Glassware for
lipid preparation was endotoxin-free which was archived by
heating the glassware at 450uC for at least 8 h. All chemicals
used were obtained as endotoxin-free from Sigma-Aldrich,
LLC (St. Louis, MO). One hundred micrograms of each of the
B. pseudomallei polar lipid fractions and lipid extracts were first
dissolved in 10 ml iso-propanol followed by addition of 90 ml
Roswell Park Memorial Institutes 1640 medium (RPMI). This
stock solution was further diluted with RPMI 1640 media to a
final concentration of 0.4 mg/ml. These final solutions were
used as antigens in caprine dendritic cells (cDCs) - T cell co-
culture stimulation assays. Concanavalin A (ConA) (5 mg/ml)
mitogen was used as the positive control, whereas complete
RPMI 1640 medium (cRPMI) (RPMI 1640 medium containing
10% fetal bovine serum, 2 mM L-glutamine, 100 mM
HEPES, penicillin [100 IU/ml], streptomycin [100 mg/ml] and
gentamicin [50 mg/ml], and 5610–5 M 2-mercaptoethanol)
served as the negative control.
MALDI-TOF of lipid fractions and spots
Matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) was performed in the Proteomics and Metabo-
lomics Facility, Colorado State University, with an Ultraflex
MALDI/TOF/TOF (Bruker Daltonics, Billerica, MA) with 2,5
dihydrobenzoic acid and NaI as the matrix.
Animal Experiments
For proof-of-concept, two female adult Nubian breed goats, 12
months (#19) and 36 months (#29) of age, were obtained from a
disease-free herd and used for these studies. Both animals
remained healthy throughout the study. Animals were bled every
two weeks for the duration of the study (18 months). This study
was carried out in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by the
Institutional Animal Care and Use Committee (IACUC) of
Colorado State University (Approval # 09-1507A).
Blood collection
Jugular venous blood (15–20 ml) was collected from goats into
EDTA tubes as needed. White blood cells were prepared by lysis
of red blood cells with Gey’s solution. Whole blood was incubated
with Gey’s solution for 5 minute followed by PBS. The mixture
was then centrifuged and the cell pellet washed three times with
Polar Lipids of Burkholderia pseudomallei
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PBS. Cells were re-suspended to a final concentration of
26106 cells/ml in cRPMI medium.
Preparation of dendritic cells
Blood-derived caprine dendritic cells (cDCs) were prepared by
culture differentiation of monocytes obtained by plastic adhesion
of white blood cells. Briefly, the white blood cells were incubated
for at least 2 h in cRPMI medium at 37uC, 5% CO2. Thereafter,
non-adherent cells were removed and adherent monocytes were
rinsed with sterile PBS. Adherent monocytes were incubated for 7
d at 37uC, 5% CO2 in cRPMI medium containing 2 ng/ml of a
cocktail of cytokines containing a chimeric recombinant bovine
Flt3L/GM-CSF and bovine IL-4 [27]. The recombinant cytokines
used in this protocol were expressed as FLAG-tagged proteins in
HEK 293 Free-Style cells (Invitrogen) and affinity-purified using
anti-FLAG M2-agarose beads (Sigma-Aldrich). Live cDCs were
visualized and images were captured using a LSM 510 Zeiss
confocal microscope. The surface antigen phenotype of the cDCs
was determined by flow cytometric analysis using monoclonal
antibodies (mAbs) specific for anti-bovine CD1w2 (CC20; AbD
Serotec), mouse anti-ovine MHC class II DR (AbD Serotec) and
anti-human CD14 (M5E2; BioLegend). Caprine dendritic cells
were stimulated for 16 h with each one of the polar lipid fractions
described above. For this purpose, the cDCs (16105 cells/well)
were incubated with each one of the polar lipid fractions at
0.4 mg/ml in a total volume of 100 ml complete RPMI. In those
experiments aiming to block the CD1w2 antigen, cDCs pulsed
with each of the lipid fractions were pre-incubated for 1 h with
purified anti-CD1w2 antibodies prior to adding T cells.
T cell isolation
T cells present in the white blood cells were isolated using nylon
wool columns as reported earlier [28]. Briefly, white blood cells (5–
66107 cells/10 ml of cRPMI) were loaded onto sterile nylon wool
columns and incubated for 30 min at 37uC. Then the columns
were placed in a support and T cells (non-adhered to nylon wool)
were recovered by eluting the columns using cRPMI medium and
the cells were concentrated by centrifugation. Thereafter, cells
were stained with fluorescence labeled mAbs against CD4 and
CD8 T cell markers (AbD Serotec). This procedure resulted in
approximately 85% enrichment of the T cells from the original
blood white cell suspension. Isolated T cells were co-cultured with
antigen-pulsed cDCs [at a ratio of 5:1] for 72 h or 7 d depending
on the assays. After 72 h some co-cultures received 2 ng/ml of
bovine IL-2 (Kingfisher, Biotech Inc.) and they were incubated for
5 d after which intracellular cell cytokine assays were performed as
explained below.
T cell stimulation studies
In some experiments, T cells were labeled with carboxyfluor-
escein diacetate succinidyl ester (CFSE) dye [CellTRAceTMCFSE
dye, Invitrogen] following the manufacturer’s recommendations.
CFSE-labeled T cells were used to determine the antigen specific
proliferation capacity of CD4+ T cells in the presence of cDCs and
each polar lipid fraction extracted from B. pseudomallei. After 72 h
of culture, the cells were harvested and stained with fluorescence
labeled anti-ovine CD4 mAb (clone 44.38; AbD Serotec). There-
after, cells were evaluated by flow cytometry and CD4+ T cell
proliferation was determined by measuring the loss in the intensity
of CFSE fluorescence. ConA (5 mg/ml) treated cells served as the
positive control, whereas CFSE-labeled T cells cultured in
medium alone served as the negative control. In another assay,
unlabeled T cells and antigens were added to cDCs and 72 h later
cells were harvested and subjected to cell surface staining for T cell
activation markers using fluorescence labeled anti-ovine CD4
mAb and anti-bovine CD25 mAb (clone 9.14) (AbD Serotec).
The profile of cytokines expressed by T cells after 7 d of culture
in the presence of autologous cDCs and each of the polar lipid
fractions extracted from B. pseudomallei was determined by
intracellular staining using fluorescence anti-IFN-c or IL-10 mAbs
(AbD Serotec). For this purpose, prior to the staining procedure,
each culture was incubated with leukocyte activating cocktail
containing Golgi Plug (BD Biosciences) for 6 h as per manufac-
turer’s instructions and then the cells were stained with the
fluorescence labeled anti-ovine CD4 mAb. Thereafter, the cells
were incubated with BD Cytofix/Cytoperm reagents (BD
Bioscience) and stained with antibodies against bovine IFN-c
(clone CC302), mouse IL-10 (clone JES5-2A5), or mouse and rat
negative controls IgG1 (AbD Serotec) to determine the cells
producing these cytokines. The stained cells were tested by Flow
Cytometry Cyan (Beckman Coulter) and the data acquired was
analyzed using the FlowJo software (TreeStar, Ashland, OR). Gate
strategy included selection of cell populations according to their
side/forward scatter profile. Thereafter, CD4+ T cells with positive
cytokine staining for each gate was compared to their correspond-
ing isotype-matched control and the percentage of positive cells
and intensity of fluorescence was recorded as percentage of
positive cells and mean fluorescence channel (MFC), respectively.
The significance of the difference (presented as the percentage of
positive cells) between co-cultures of B. pseudomallei lipid-pulsed
cDCs with T cells and the negative control co-cultures was
determined by statistical analysis of the Overton subtraction of
percentage of positive cells using the FlowJo software.
Results
Total lipids of B. pseudomallei
Total lipids of B. pseudomallei (termed F1) were obtained through
the first extraction of cell lipids. There were at least 23 different
Table 1. Solvent systems used for two-dimensional thin layer chromatography.
Polarity Name 1st Dimension 2nd Dimension
Polar B Chloroform/methanol/water (60:30:6) Chloroform/acetic acid/methanol/water (40:25:3:6)
Q A Chloroform/methanol/water (100:14:0.8) Chloroform/acetone/methanol/water (50:60:2.5:3)
E Chloroform/methanol (96:4) Toluene/acetone (80:20)
C Petroleum ether/acetone (92:8) Toluene/acetone (95:1)
Apolar D Petroleum ether/ethyl acetate (98:2) Petroleum ether/acetone (98:2)
doi:10.1371/journal.pone.0080368.t001
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lipid spots identified by two-dimensional thin layer chromatogra-
phy within the five different solvent systems (Figure 1). While
most of the non-polar lipids appeared only under UV light all
other lipid spots could be visualized by the general stain with
CuSO4 in H3PO4.
Polar lipids of B. pseudomallei
Polar lipids (termed F2) were obtained through the second
extraction from the B. pseudomallei cell envelope. Two-dimensional
thin layer chromatography (2D-TLC) identified nine lipid spots
when using the most polar solvent system B (Figure 2).
Figure 1. Composite sketch of total lipids of B. pseudomallei. Lipids shown were found within the first extract in five different solvent systems
from very polar to highly non-polar (B, A, E, C, D). Colors of various lipid spots represent different staining and detection methods: Maroon Red: Spots
detected as dark spot under UV light; Strawberry Red: Spots detected as a bright spot under UV light; Steel gray: Spots detected by spraying with
CuSO4 in H3PO4; Blue: Spots detected by spraying with Dittmer-Lester reagent; Plum purple: Spots detected by spraying with ninhydrin as molecules
containing primary amino groups; Red: Spots detected by spraying with ninhydrin as molecules containing secondary amino groups; Orange: Spots
detected by spraying with ninhydrin as molecules containing tertiary amino groups/proline; Magenta: Spots detected by spraying with a-naphthol.
doi:10.1371/journal.pone.0080368.g001
Figure 2. Composite sketch of polar lipids of B. pseudomallei. Lipids are shown as found within the second extract in the highly polar solvent
system B. Colors of various lipid spots represent different staining and detection methods: Maroon Red: Spots detected as dark spot under UV light;
Strawberry Red: Spots detected as a bright spot under UV light; Steel gray: Spots detected by spraying with CuSO4 in H3PO4; Blue: Spots detected by
spraying with Dittmer-Lester; Plum purple: Spots detected by spraying with ninhydrin as molecules containing primary amino groups; Red: Spots
detected by spraying with ninhydrin as molecules containing secondary amino groups; Orange: Spots detected by spraying with ninhydrin as
molecules containing tertiary amino groups/proline; Magenta: Spots detected by spraying with a-naphthol.
doi:10.1371/journal.pone.0080368.g002
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Differential staining of 2D-TLCs demonstrated the presence of
charged lipids (lipid spots 15 to 18), sugar containing lipids (lipid
spot 17), and lipids with primary amino groups (lipid spot 16, 18,
and 22), secondary amino groups (lipid spots 19 and 20), or
tertiary amino groups including proline (lipid spot 23). Further
fractionation of the second extract (polar lipids) resulted in four
significant fractions with either single lipid spots or only few lipids
spots (Figure 1C). Fraction F4 contains only lipid 16 while
fraction F7 contains only lipid 19. In contrast to these two
fractions, fractions F5 and F6 were a mix of a few lipids with but
did not contain lipid spots 16 and 19. In particular, fraction F5
contained lipid spots 16, 17, and 18, while fraction F6 contained
lipid spots 16, 18, 19. Lipid spot 17 was the only lipid spot that
stained positive with a-naphthol indicating that it contains the
glycolipids known as rhamnolipids, the only known glycolipids of
B. pseudomallei. Lipid spot 16 stained positive for primary amino
groups and positive for charged lipids. Lipid spot 18 contains
charged lipids and the molecular ions suggest that it contains the
well-known inner membrane phospholipid phosphatidylethanol-
amine (PE). Lipid spot 19 could not be further characterized.
However, we did determine that lipid spot 19 contains a secondary
amino group and it is neither a charged lipid nor a glycolipid.
MALDI-TOF of lipid fractions and lipid spots
Mass spectrometry (MS) and MS/MS were performed by
MALDI-TOF using sodium 2,5 dihydrobenzoate resulting in
primarily sodium-based positive ions. MALDI-TOF was per-
formed for lipid spots 16 to 19 and polar lipid fractions V to VIII
(Figures 2, 3, 4). MALDI-TOF MS data were combined with MS/
MS data of key ions within each polar lipid fraction.
Figure 3A shows the mass spectrometry of primarily lipid spot
16, which is dominated by the ions of 563.30, 591.34, and two
minor ion of 550.39 and 603.35 u. MS/MS analyses demonstrated
clearly the presence of ornithine lipid within the ions of 563.30 u,
591.34 u, and 603.35 u (M+Na+) (Figure 4). Fragmentation of
this ion resulted in the loss of ornithine (132.5 u) and yielded
fragmentation ions of 408.69 u, 436.74 u, and 448.75 u,
respectively. Thus, the predicted preliminary structure most likely
consists of one C12 and one C14 fatty acyl group with one of them
being 3-hydroxylated, while the other moiety is bound to the
ornithine. The molecular ion of 591.34 would thus represent an
ornithine lipid with one C14 and one 3-OH C14 fatty acyl group,
while the molecular ion of 603.35 contains a mono-unsaturated
fatty acid and saturated fatty acid. One of these lipids is
hydroxylated. The lengths of the fatty acyl chains should be C14
and C15.
Figure 3. Mass spectrometry of the four major fractions of polar lipids. Lipids derived from the second lipid extract of B. pseudomallei. Each
mass spectrometric trace has the lipid composition of its fraction indicated by a 2D-TLC plate in the upper right corner. Lipid spot numbers
correspond to those used in Figures 1 and 2. Major ions of each spot are highlighted in colored boxed. Molecular ions are in bold and enlarged in
panels they first appeared. Panel A represents lipid fraction V (F4); panel B represents lipid fraction VI (F5); panel C represents lipid fraction VII (F6);
and panel D represents lipid fraction VIII (F7).
doi:10.1371/journal.pone.0080368.g003
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Figure 3B shows the MALDI-TOF MS data of lipid spots 16,
17, and 18. Although already demonstrated by differential staining
for carbohydrates, MALDI-TOF MS/MS for lipid spot 17
(molecular ion of 785.59 u) demonstrated the presence of a C14/
C14 di-rhamnolipid (Figure 5). Our data confirm the previously
determined presence and chemical structures of rhamnolipids of B.
pseudomallei [22,23,29,30]. The key molecular ion of spot 18 was
the ion of 726.44 u. Differential staining of lipid spot 18 pointed
already in the direction of putative phospholipids within spot 18
and indeed ions for C16/C18 PE (742.57 u), C16/C16 PE (714.47
u), and C16/C17:1 PE (726.44 u) could be identified.
Figure 3C and D show the presence of lipid spot 19 and to
some extent spot 20 in fractions VII and VIII. Differential staining
of both lipid spots did not reveal any specific moieties within the
lipids of these spots except that the molecules in these spots contain
secondary amino groups.
Characterization of caprine blood derived dendritic cells
It is known that presentation of lipids to T cells is mediated by
dendritic cells (DC) expressing the CD1 cluster of antigens [26].
Among those, the CD1b and CD1c have demonstrated capacity to
present lipids to T cells and play a role in protection against
mycobacteria [25]. We prepared cultures of monocyte-derived
caprine DC (cDCs) from goat peripheral blood. Goat blood
adherent monocytes were cultured in the presence of recombinant
bovine GM-CSF-FLt3L and recombinant bovine IL-4 for 7 days.
The cells in these cultures demonstrated classic morphology of
dendritic cells when examined by confocal microscopy
(Figure 6A). Cells from these cultures were also characterized
by flow cytometric analysis for expression of the monocyte marker
CD14 and the well-described DC subset markers CD1w2 (also
known as CD1b) and MHC class II DR molecules. To detect these
molecules on the surface of cDCs we used fluorescent labeled anti-
bovine CD1w2 and anti-ovine MHC class II DR mAbs. These
experiments demonstrated that cells in these cultures were positive
for CD14, CD1w2 and MHC class II DR antigens (Figure 6A).
Thus, we concluded that, as expected, goat adherent monocytes in
the presence of a cocktail of bovine Flt3L/GM-CSF and bovine
IL-4 differentiated into monocyte-derived DCs.
Furthermore, we studied whether each of the polar lipid
fractions extracted from B. pseudomallei had any effect on the
surface expression of CD1w2 and MHC class II DR antigens on
cDCs. For this purpose, cDCs were incubated for 16 h with each
of the polar lipid fractions and the cell surface expressions of
CD1w2 and MHC class II DR antigens were determined by flow
cytometry. The surface expression for CD1w2 molecules on cDCs
was up regulated by all polar lipid fractions when compared to
similar cDCs in control cultures (Figure 6B and C). However,
the expression of MHC class II DR antigens on cDCs recovered
from the same cultures was down regulated or did not change
Figure 4. Mass spectrometry analysis by MALDI-TOF-TOF of the four major molecular ions of lipid spot #16. Arrows highlight the
difference between two major ions representing the loss of ornithine.
doi:10.1371/journal.pone.0080368.g004
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when compared to similar cDCs cultured in medium alone
(Figure 7). Interestingly, cDCs derived from goat #19 and
cultured in the presence of polar lipids derived from fractions F4 –
F7 had the highest increase in mean MFC and percentage of
positive cells for CD1w2 antigens when compared to the
expression of the same antigen in cells recovered from cultures
containing F1 or F2 extracts, total and polar lipids, respectively
(Figure 6C). The MFC and percentage of expression of CD1w2
and MHC class II DR varied between cultures of cDCs obtained
from different animal subjects but followed similar trend of
changes between animals.
T cell responses to caprine dendritic cells pulsed with
each of the B. pseudomallei lipid fractions
The capacity of lipids to stimulate T cells is an important step
towards activation of the acquired immune response. Priming of T
cells requires up regulation of the CD25 molecules (IL-2 receptor),
IL-2 expression and subsequent cell proliferation. Thus, using flow
cytometry, we measured the capacity of T cells to proliferate and
to up regulate expression of the CD25 molecules in response to B.
pseudomallei polar lipids present in each of the lipid fractions. First,
we measured the capacity of cDCs pulsed with each of the polar
lipid fractions to stimulate proliferation of T cells. Proliferation in
these cultures was determined by measuring the loss of fluores-
cence in the CFSE labeled CD4+ T cell population (Figure 8A).
The results demonstrated that CD4+ T cells recovered after 72 h
from co-cultures containing cDCs and CFSE-labeled T cells in the
presence of each polar lipid fraction demonstrated higher
proliferation than similar CD4+ T cells in control co-cultures.
Similar co-cultures assays demonstrated that the percentage of
CD4+ positive T cells expressing CD25 antigens increased
between 10 and 20% in cells recovered from co-cultures
containing B. pseudomallei polar lipid fractions than similar cells
obtained from control co-cultures (Figure 8B and C). Again,
changes in the percentage of positive cells and MFC varied
between cell cultures derived from different animal subjects but
similar trends of proliferation and CD25 expression were observed
in cells derived from both goats.
Cytokine profile of T cells recovered from co-cultures
containing each one of the B. pseudomallei polar lipid
fractions
The profile of cytokines expressed by T cells upon stimulation,
in this case IFN-c and IL-10, is likely to determine the outcome of
the acquired immune responses towards a protective state of the
host. For this reason we screened each of the B. pseudomallei polar
lipid fractions for their capacity to stimulate IFN-c and/or IL-10
expression by T cells recovered from these co-cultures. Cells
recovered from each of the co-cultures were stained for co-
expression of CD4 and IFN-c (Figure 9) or IL-10 (Figure 10)
cytokines. Flow cytometric analysis of T cells co-cultured for 7 d
with cDCs pulsed with B. pseudomallei polar lipid fractions showed
that CD4+ T cells expressed IFN-c and IL-10 (Figures 9 and 10).
Depending on the culture conditions, and when compared with
their isotype-matched controls, 10–40% IFN-c+CD4+ T cells were
detected in each co-culture (Figure 8A). Comparison of IFN-c
expression by CD4+ T cells between the treatment and the
controls revealed that only cells co-cultured in the presence of
polar lipid contained in fraction F5 (in both goats #19 and #29),
and polar lipids contained in fraction F4 and F2 (only in goat #29)
had increased MFC (Figure 9B). Interestingly, cells in co-cultures
stimulated with any of the lipids fractions contained higher
percentage (between 1–7%) of IFN-c+CD4+ cells than in control
co-cultures. Furthermore, IFN-c+CD4+ cells from co-cultures
Figure 5. Mass spectrometry analysis by MALDI-TOF-TOF of the key molecular ions of lipid spot#17. Arrows highlight the differences
between two major ions representing the loss of rhamnose. Molecular ions representing fragmentation ions are labeled.
doi:10.1371/journal.pone.0080368.g005
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pulsed with polar lipids from fractions F4 and F5 had the highest
percentage (4–7%) of positive cells among all the lipid fractions
tested (Figure 9C). Cells from these co-cultures tested positive for
IL-10 expression when compared to the control (Figure 10A). In
this case, polar lipids from fraction F7 followed by F6 have the
highest MFC and higher percentage of CD4/IL-10 positive cells
(20–35%) when compared to cells harvested from control cultures
(Figure 10B).
CD1w2 contribution to IFN-c expression by CD4+ T cells
Contribution of the CD1w2 expressed on the surface of
cDCs during the presentation of polar lipids contained in fractions
F4 – F7 to autologous T cells was evaluated by using mAb to block
the CD1w2 molecules expressed on the surface of cDCs.
Incubation of cDCs with CD1w2-specific mAb followed by
incubation with the same antibody conjugated to PE showed that
the unlabeled CD1w2-specific mAb blocked binding of the PE-
labeled anti-CD1w2 mAb by 54% (Figure 11A). In co-culture
experiments conducted using cDCs pre-incubated with the
CD1w2-specific mAb after stimulation with the lipid fractions
and prior to the addition of autologous T cells, the expression of
IFN-c by CD4+ cells was considerably reduced as judged by
reduction in MFC (Figure 11B and C). Taken together, these
data suggest that CD1w2 molecules present on the cDCs play a
role in activation of CD4+ T cells to produce IFN-c by B.
pseudomallei polar lipids.
Discussion
While it has been long recognized that bacterial lipids are
excellent diagnostic markers, we and others have demonstrated
that bacterial polar lipids can also stimulate specific immune
responses in the host [24,31]. Here we demonstrated that polar
lipids of B. pseudomallei (e.g. ornithine lipids and rhamnolipids)
induce antibody production and that most polar lipids stimulate
cellular immune responses. In this study, we fractionated polar
lipids derived from the cell wall of B. pseudomallei strain K96243
and evaluated their capacity to stimulate antigen-specific responses
Figure 6. Characterization of caprine peripheral blood monocyte-derived dendritic cells. Panel A shows a photograph of a classic
morphology of a caprine dendritic cell. The same cultures were examined for cell surface expression of myeloid dendritic cell markers: CD14, MHC
class II DR, and CD1w2 antigens. In panel B are representative histograms for cell surface expression of CD1w2 antigen (dark line) or isotype matched
control (dotted line) in caprine dendritic cells from goat #19 (top and framed in red) and goat #29 (bottom and framed in blue) when cultured in
media alone. Panels C and D correspond to cell surface expression of CD1w2 antigen in caprine dendritic cells when cultured for 16 hours in culture
media alone or culture media with ConA, first extraction of total cell lipids of B. pseudomallei (F1), second lipid extract (F2), or lipid fraction of the
second lipid extract (F4 to F7). Panel C represents the mean Fluorescence Channel (MFC) for CD1w2 expression in each culture. Panel D represents
the percentage of positive cells for CD1w2 when compared to media alone.
doi:10.1371/journal.pone.0080368.g006
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Figure 7. Surface expression of MHC class II DR antigens on caprine dendritic cells and effect of polar lipid fractions on surface
expression for these molecules. Panel A shows representative histograms of surface expression of MHC class II DR molecules on cDCs cultured
(dark line) or isotype matched control (dotted line) with culture media alone. Panels B and C correspond to cell surface expression of MHC class II DR
molecule on cDCs when cultured for 16hr in culture media alone or culture media containing ConA or each of the polar lipid fractions (F1 to F7)
extracted from B. pseudomallei as described in Figure 1. Panel C represents the Mean Fluorescence Channel (MFC) for MHC class II DR antigen
expression in each cell culture. Panel D represents the % of positive cells for MHC class II DR antigen over the percentage of positive cells expressing
MHC class II DR antigen on cDCs cultured in media alone.
doi:10.1371/journal.pone.0080368.g007
Figure 8. Autologous T cell activation by caprine dendritic cells. Autologous T cells were pulsed with media alone, ConA, first lipid extraction
(F1), second lipid extraction (F2), and lipid fractions of F2 (F4 to F7). Panel A shows the proliferation of CD4 T cells when co-cultured with cDCs pulsed
with B. pseudomallei polar lipid fractions (F1 to F7). The vertical dashed box within the histograms represents the threshold expression of CFSE below
which cells were considered to have lost more fluorescence for the CFSE dye than CD4+ T cells harvested from the cultures containing media alone.
Panel B represents the Mean Fluorescence Channel (MFC) for CD25 antigen expression in each cell culture. Panel C represents the percentage of
positive cells for CD25 antigen over the percentage of positive cells expressing CD25 antigen on cDCs cultured in media alone obtained by Overton
statistical analysis using the FlowJo software package. Upper and lower histograms or bar graphs correspond to animal #19 and #29, respectively.
doi:10.1371/journal.pone.0080368.g008
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by caprine CD4+ T cells given that goats are natural host for this
bacteria. We obtained four major fractions (depicted in Figure 1C
as F4, F5, F6, and F7) containing few or single polar lipids and
analyses of lipids contained in each fraction by mass spectrometry
revealed that fraction F4 contained ornithine lipids; fraction F5
contained ornithine lipids, rhamnolipids, and phospholipids
(mainly phosphatidylethanolamine [PE]); fraction F6 contained
ornithine lipids, PE lipids and lipid spot 19; whereas fraction F7
contained only lipid spot 19. While the chemical structures of
rhamnolipids, ornithine lipids, and phospholipids of B. pseudomallei
or closely related Pseudomonas ssp. were already determined by
others [20,21,22,32,33,34,35,36] the major focus of this study was
to determine the involvement of polar lipids of B. pseudomallei in the
induction of host immune responses. We tested the capacity of
each one of these B. pseudomallei polar lipid fractions to stimulate
immune responses in cell cultures derived from caprine peripheral
blood white cells. We generated and used monocyte-derived
caprine dendritic cells (cDCs), and showed that they displayed the
classical DC morphology, and expressed CD14, MHC class II
DR, and CD1w2 cell surface markers. While these markers are
not exclusive for dendritic cells, together with the microscopic
appearance of these cells, however, led us to conclude that these
cells are truly dendritic cells. Thus, this is the first report
to demonstrate that recombinant bovine cytokines (IL-4 and
Flt3L/GM-CSF) stimulated caprine monocytes to differentiate to
DCs. These data also demonstrated a preferential effect of B.
pseudomallei polar lipids contained in fractions F4 – F7, on the
surface expression of CD1w2 antigens than on the surface
expression of MHC class II DR antigens by the cDC.
It is already known that CD1 molecules present mainly lipid
antigens, whereas MHC class II DR molecules present peptides
[25,37,38,39,40]. It is believed that activation of the protective
responses mediated by polar lipids and the CD1 pathway has great
advantages when compared to peptide presentation to T cells by
the MHC. Thus, unlike the MHC pathway of antigen presenta-
tion, the CD1 pathway benefits from highly conserved CD1
antigen expression between species and individual subjects.
Surprisingly, our data showed that interaction of each of the B.
pseudomallei polar lipid fraction with the cDCs preferentially up-
regulated the expression of CD1w2 molecules on the surface of the
DCs but not the expression of MHC class II DR molecules. This
capacity appears to allow the polar lipids contained in each of the
lipid fractions to be recognized partly by CD1w2 restricted T cells
and trigger expression of IFN-c which is associated with protective
immune responses. Altogether we believe these data have great
potential within the vaccine development field.
Analyses of each fraction derived from B. pseudomallei demon-
strated that fractions F4 to F7 contained only partial numbers of
lipid moieties than the total lipids found in F1 and of the total
polar lipids found in F2. Interestingly, the immunological
responses elicited by lipids contained in fractions F4 to F7 also
demonstrated a preferential capability to stimulate protective
(IFN-c) or immunosuppressive (IL-10) responses. While most
studies on cellular immune responses induced by bacterial antigens
Figure 9. IFN-c expression in CD4+ T cells. Panel A shows representative flow cytometry plots demonstrating positive staining for CD4 and IFN-c
staining in cells recovered from co cultures of autologous T cells and cDCs with fraction F4 extracted from B. pseudomallei. Panel B represents the
Mean Fluorescence Channel (MFC) for CD4/IFN-c positive cells in each cell culture. Panel C represents the % CD4/IFN-c positive cells over the
percentage of positive cells expressing CD4/IFN-c cultured in media alone.
doi:10.1371/journal.pone.0080368.g009
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have to eliminate endotoxins, preparation of lipid antigens
through Folch wash eliminate the highly water soluble endotoxin
and thus, we are certain that our data are not influenced by
endotoxins. Fractions F6 and F7 induced much more IL-10 than
IFN-c, whereas F4 and F5 stimulated more IFN-c than IL-10.
Furthermore, the first (F1) and second (F2) extraction of B.
pseudomallei lipids provided a more balanced immune response
(IFN-c and IL-10 cytokine expression), which is not a surprise
since those are a combination of either all cell envelope lipids (F1)
or contain all polar lipids including the polar lipids of the four
fractions also tested (F2). The latter indicates that the effect on the
cytokine responses stimulated in T cells by polar lipids is (a) lipid-
specific and (b) depends on the amount present in the lipid
cocktail. This is also supported by our data clearly demonstrating
that ornithine lipids stimulate IFN-c either alone as in fraction F4
or in combination with rhamnolipids and PE as in fraction F5.
Ornithine lipids are found in a variety of bacterial species
including various Pseudomonas species (P. aeruginosa, P. stutzeri, and
B. cepacia]). Kawai and colleagues [30] reported previously that
ornithine lipids derived from Flavobacterium meningosepticum are
immune reactive and act as adjuvants to enhance immune
responses when used with LPS of B. cepacia. The same authors
also demonstrated that ornithine lipids protect mice from lethal
endotoxemia [30,40]. Thus, in our study the capacity of ornithine
lipids derived from B. pseudomallei to stimulate IFN-c responses is in
line with those studies from Kawai and suggest that the ornithine
Figure 10. IL-10 expression in CD4+ T cells. Panel A shows the representative flow cytometry plots demonstrating positive staining for CD4 and
IL-10 staining in cells recovered from co cultures of autologous T cells and cDCs with media alone, fraction F4 and F7 extracted from B. pseudomallei.
Panel B represents the mean fluorescence channel (MFC) for CD4/IL-10 positive cells in each cell culture. Panel C represents the percentage CD4/IL-10
positive cells over the percentage of positive cells expressing CD4/IL-10 cultured in media alone.
doi:10.1371/journal.pone.0080368.g010
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lipids derived from B. pseudomallei may have potential use as
adjuvants.
We also demonstrated that fraction F5 containing rhamnolipids
and ornithine lipids did not stimulate IL-10. The lack of
stimulation of IL-10 in cultures containing fraction F5 suggest
that neither the ornithine lipids nor the rhamnolipids are good
stimulators of IL-10 production when exposed to caprine cells.
Rhamnolipids are known to be key cell surface molecule in various
bacterial species including Pseudomonas ssp. and Burkholderia ssp.
[32,41]. Rhamnolipids are present in B. pseudomallei and they
exhibit strong serological activities and induce cellular and
functional changes in cell lines. Interestingly, the rhamnolipids
from B. pseudomallei were found to be hemolytic for various
erythrocyte species and to have cytotoxic effect for nonphagocytic
and phagocytic cell lines [32,33]. However, no data were provided
yet until now that rhamnolipids from B. pseudomallei were capable
of stimulating IFN-c cytokine production by CD4+ T cells.
Although we were unable to detect lipid A or deep rough LPS in
our polar lipid fractions it has to be mentioned that rhamnolipids
and perhaps ornithine lipids exhibit strong endotoxin-like prop-
erties and this might be the reason that both molecules induce
IFN-c. Several studies focused on the structural properties of
glycolipids including lipid A, deep rough LPS, rhamnolipids and a
glycoglycerolipid from Mycoplasma fermentans and how the chemical
structure would contribute to the endotoxin-like properties of the
lipids. While several of these lipids have acyloxyacyl moieties
(rhamnolipids, hexaacyl Lipid A, heptaacyl Lipid A, haxaacyl deep
rough LPS) and one might have hypothesized that this would be
the key structural component leading to endotoxin-like properties,
it was nicely shown that it is required for endotoxicity to have an
amphiphilic lipid molecule with a nonlamellar cubic aggregate
structure with a sufficiently high negative charge density in the
saccharide-based backbone. This model would explain the
endotoxicity of the glycoglycerolipid of M. fermentans, which does
not have an acyloxyacyl structure but has the proposed
nonlamellar cubic aggregate structure [42,43,44,45].
Finally, our data suggest that lipid spot 19 found in fraction F6
and in fraction F7 is responsible for the IL-10 stimulation in
caprine cells and that the inner membrane bacterial phospholipids
(all are PE in our analyses) found in fractions F5 and F6 seemed
not to contribute to the overall immune responses. However, PE
may have a role in activation of B cells to produce antibody since
in other studies it has been shown that purified PE induce antibody
production [46]. In another study by Morgan and colleagues,
murine peritoneal macrophages stimulated with PE induced TNF-
a production [47] and may be implicated in activation of TLR.
Lipid spot 19 seems to be an important immune suppressive polar
lipid and might contribute to the overall immunosuppressive host
responses during and after infection. While our data are a first
indication for this hypothesis, further evaluation of the immune
Figure 11. CD1w2 blocking effects on IFN-c expression by CD4+ T cells when stimulated with polar lipids. Panel A show the histogram
representing the MFC for CD1w2-PE antibody bound to cDC cultures incubated with fluorescence -CD1w2 antibody-PE (thick line, MFC= 9540) or
with purified CD1w2 antibody plus CD1w2 –PE antibody [thin-dotted line, MFC 5070]. Panels B and C show representative histograms (B) and dot
plots (C) of CD4 T cells expressing IFN-c recovered from cultures after seven days incubation where the cDCs primed with each of the polar lipids
when incubated with CD1w2 antibody (right column of dot plots) or without (left column of dot plots). Numbers inside the quadrants indicated the
percentage (upper number) and the MFC (lower number) for IFN-c expression in the CD4+ (right quadrants) and CD4- negative cells (left quadrants).
doi:10.1371/journal.pone.0080368.g011
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responses due to lipid spot 19 are needed to confirm this
hypothesis. Furthermore, it has to be shown that this lipid spot
is present in the lipid profiles of B. pseudomallei when grown
intracellular and/or in vivo.
Future studies using goats that are either experimentally or
naturally infected with B. pseudomallei will determine if the
immunological properties for each polar lipid identified in these
studies can be used as T cell biomarker of disease progression, as
vaccine/adjuvant candidates or to develop cellular based immune
detection strategies with lipids for diagnostic purposes. Moreover,
further characterization of the polar lipids, their abundance, and
association with immune response of the host will facilitate
understanding of the pathogenesis of disease caused by pathogenic
strains of B. pseudomallei. Because it is possible to chemically
synthesize polar lipids, the use of polar lipids and their
immunological properties represent a very promising venue to
develop novel tools for the development of either vaccines or
adjuvants, or could serve as biomarkers for melioidosis. In
summary, our data demonstrated that among the polar lipids of
B. pseudomallei, ornithine lipids and rhamnolipids are strong IFN-c
stimulators and thus both support the host immune response to
control the disease, whereas the unknown polar lipid found in spot
19 of fraction F7 and F6 is on the opposite side as it strongly
stimulates IL-10. No definitive role of the immune response for PE
phospholipids could be determined.
The experiments in our study were designed as a proof-of-
concept that the polar lipids of B. pseudomallei can induce strong
cellular immune responses and that their presences or absences in-
vivo needs to be evaluated. Although only two animals were used in
this study, experiments were repeated several times to eliminate
one-time effects. Our data provide convincing evidence that these
polar lipids can contribute to pathogenicity and intracellular
survival of B. pseudomallei during infection of at least goats if not
humans.
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